Evidence map›Paper›PMID 32987931›Full record

ArticlePolymers2020

The Potential of Graphene Nanoplatelets in the Development of Smart and Multifunctional Ecocomposites.

Pedro Pereira, Diana P Ferreira, Joana C Araújo, Armando Ferreira, Raul Fangueiro

Abstract read
In one paragraph

Article in Polymers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pedro PereiraCentre for Textile Science and Technology (2C2T), University of Minho, 4710-057 Guimarães, Portugal.
Diana P FerreiraCentre for Textile Science and Technology (2C2T), University of Minho, 4710-057 Guimarães, Portugal.ORCID 0000-0002-7862-4687
Joana C AraújoCentre for Textile Science and Technology (2C2T), University of Minho, 4710-057 Guimarães, Portugal.
Armando FerreiraCenter of Physics, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0002-5294-0112
Raul FangueiroCentre for Textile Science and Technology (2C2T), University of Minho, 4710-057 Guimarães, Portugal.ORCID 0000-0003-3303-6563

Funding

Fundação para a Ciência e a Tecnologia FCT
6 · The paper itself

Abstract

Graphene and its derivatives have shown outstanding potential in many fields and textile/composites industry are not an exception. Giving their extraordinary properties, Graphene Nanoplatelets (GNPs) are excellent candidates for providing new functionalities to fibers and composites. In this work, natural fabrics (flax) were functionalized with chitosan (CS) based polymeric formulations of GNPs to develop fibrous systems with electrical properties as well as other functionalities. One of the greatest disadvantages of using carbon-based materials for fabrics' impregnation is their difficult dispersion. Therefore, several polymers were used as matrices, binding and dispersive agents including chitosan, polyethylene glycol (PEG), and glycerol. All the systems were characterized using several techniques that demonstrated the presence and incorporation of the GNPs onto the composites. Besides their characterization, considering their use as smart materials for monitoring and sensing applications, electrical properties were also evaluated. The highest value obtained for electrical conductivity was 0.04 S m

Indexed as

biodegradable polymersGNPsmultifunctional ecocompositenatural fiberspiezoresistive behavior

Identifiers

PMID32987931
PMCPMC7600018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.